Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SB-121
- Development stage
- Phase 1
- Lead developer
- Scioto Biosciences
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
SB-121 is a live biotherapeutic product (LBP) consisting of a proprietary formulation of the bacterium *Lactobacillus reuteri*. Developed by Scioto Biosciences using its Activated Bacterial Therapeutics (ABT) platform, SB-121 is designed to promote the formation of bacterial biofilms, which enhances the colonization, stability, and efficacy of the therapeutic bacteria in the gastrointestinal tract. The candidate is primarily being investigated for the treatment of Autism Spectrum Disorder (ASD), targeting the gut-brain axis to improve behavioral symptoms, and for Necrotizing Enterocolitis (NEC) in premature infants. Scioto Biosciences, which is majority-owned by Genome & Company, has advanced SB-121 into Phase 1 clinical development for ASD.
- Other names
- Lactobacillus reuteri formulationActivated Bacterial Therapeutic SB-121
Beyond the preview
Go deeper on SB-121.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SB-121.